 |
|
|
|||||
Sudeep Pharma plans to raise 95 crore for capex and expand manufacturing capacity by 50,000 tonnes by March 2026. Despite strong export revenue and profit growth, investors may await post-listing performance due to high customer concentration and increased working capital days. The company seeks a P/E multiple of up to 48.
Category:
News and Media
Why - in an age where so many of us are feeling the financial pinch - are some budget shops on UK high streets having such a tough time?
Category:
News and Media
Why - in an age where so many of us are feeling the financial pinch - are some budget shops on UK high streets having such a tough time?
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||